Predictive Biotech’s Wharton’s Jelly human cell and tissue product (HCT/P), WJ Flow™ (Wharton’s Jelly Flow), is derived from donated, full-term birth tissue. Equipped with state-of-the-art analytical equipment to ensure the safety and viability of its allografts, Predictive Biotech’s laboratory and proprietary processes maintain the tissue’s biological components, yielding a normalized dose. WJ Flow is primarily comprised of epithelial cells, endothelial cells, perivascular cells, mesenchymal stromal cells (MSCs), cytokines, growth factors, exosomes, and scaffolding proteins.WJ Flow Characterization Report
Our lab is located in Research Park on the University of Utah’s campus. Focused on safety and product consistency, we are equipped with cutting-edge, scientific technologies necessary for the production of human cell and tissue products.
o 42,000 square feet
o two ISO 7 cleanrooms
o 18 ISO 5 biosafety cabinets
Standards and Regulations:
o FDA-registered: FEI 3012707547
o Current Good Manufacturing Practice (cGMP)
o Current Good Tissue Practice (cGTP) standards.
Our Human Cell and Tissue Products (HCT/Ps) are not FDA approved or licensed for the prevention, treatment, diagnosis, mitigation and/or cure of any disease or condition, including COVID-19.